The U.S. cannabis industry remains on a strong growth path, with projections estimating a $45 billion market in 2025. More than 20 states now allow adult recreational cannabis use, while others continue expanding medical programs. Recently, lawmakers have debated cannabis reform at the federal level, including rescheduling cannabis to a lower-risk drug classification. This shift could bring major tax relief and open new financial opportunities for cannabis companies. Despite challenges, these changes are fueling optimism across the sector. Penny stocks in this space offer low entry prices and potential for large percentage gains. As the market responds to legislative updates, investor attention has increased on smaller-cap cannabis plays with aggressive growth plans.

Although these stocks carry promise, they also come with significant risks. Many are highly volatile and trade with low daily volume. For this reason, using technical analysis is crucial when watching or trading marijuana penny stocks. Traders should examine key support and resistance levels. It is also smart to use volume indicators and trend confirmation tools. Setting stop-loss orders and managing position sizes can reduce exposure to large losses. Since these stocks can react sharply to news, disciplined entries and exits are essential. Investors must stay alert, follow news catalysts, and apply sound risk strategies. With the right tools and timing, opportunities in marijuana penny stocks can be substantial.

U.S. Cannabis Stocks to Add to Your Radar Now

As the U.S. cannabis industry continues expanding, investors are closely watching select leaders in the sector. In addition, more states are pushing for legalization, which adds to investor optimism. As a result, top-performing marijuana companies are gaining momentum in the market. This article focuses on three U.S. marijuana stocks worth watching in May 2025: Planet 13 Holdings (PLNH), Glass House Brands (GLASF), and Cresco Labs (CRLBF).

Each of these companies has a strong presence in key U.S. markets. They also continue to evolve operationally while navigating regulatory developments. Despite short-term volatility, these stocks have shown resilience and potential for long-term growth. Below is a closer look at each of these top cannabis players, their U.S. dispensary presence, and their latest financial performance.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Top U.S. Marijuana Stocks to Watch in May 2025

1. Planet 13 Holdings Inc. (OTC: PLNH)
2. Glass House Brands Inc. (OTC: GLASF)
3. Cresco Labs Inc. (OTC: CRLBF)

Planet 13 Holdings Inc. (PLNH)

Planet 13 Holdings is best known for operating the largest cannabis dispensary in the world. This flagship location is in Las Vegas, Nevada, and spans over 112,000 square feet. The store offers a unique retail experience that blends cannabis shopping with interactive entertainment. Tourists and locals alike visit the store daily, making it a high-traffic location.

The company has also expanded into Florida, which remains one of the fastest-growing medical cannabis markets. Currently, Planet 13 operates 30 dispensaries throughout Florida. It also has one location in Illinois, bringing its total count to 32 dispensaries. Its expansion strategy focuses on large-scale stores in high-demand regions. This allows the company to maintain brand recognition and customer loyalty.

With its growing footprint and strong consumer appeal, Planet 13 remains one of the most prominent names in the cannabis industry. Its multi-state operations continue to drive future growth opportunities.

Latest Financials

In its most recent quarterly report, Planet 13 posted revenue of $28 million. This marked a notable increase from the prior year’s results. The rise in revenue was largely driven by sales in Florida and continued strength in Las Vegas. Gross profits came in at $12 million, with a gross margin just above 42 percent.

Despite solid revenue growth, the company reported a net loss of $2 million. This was due to higher operating expenses tied to expansion efforts. Its adjusted EBITDA showed a loss of $2.5 million. However, management emphasized that short-term losses were strategic. The focus remains on building long-term value through market growth.

Planet 13 has sufficient liquidity to support future investments. Management is optimistic about Florida’s contribution to revenue in future quarters. Overall, the company is positioning itself for improved profitability as it scales.

[Read More] Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025

Glass House Brands Inc. (GLASF)

Glass House Brands is a vertically integrated cannabis company based in California. The company focuses exclusively on operations within the state. It operates greenhouse cultivation, manufacturing, distribution, and retail stores. This end-to-end control gives the company strong cost advantages.

The company has multiple dispensaries under its Farmacy brand. Most of these stores are located in high-traffic areas in Southern California. In total, Glass House operates eight dispensaries throughout the state. The company is known for its high-quality, sun-grown cannabis. Its cultivation facilities are among the largest in the country.

Glass House continues to expand its greenhouse capacity. This allows it to scale production without significantly increasing costs. The company’s strategy is rooted in operational efficiency and product consistency. As a result, it has become a leader in California’s highly competitive cannabis market. Its premium brand is well recognized by both medical and recreational consumers.

Latest Financials

In its latest earnings report, Glass House generated $44.8 million in revenue, a strong year-over-year increase driven by volume growth. Seasonal demand fluctuations and wholesale pricing pressures impacted the company’s performance, but it managed to maintain growth in core retail locations.

Gross margins remained relatively stable compared to the prior quarter. However, net losses were reported due to temporary increases in labor and facility costs. Management continues to emphasize its commitment to cost control. The company is also investing in automation to enhance productivity.

Cash reserves remain healthy and support ongoing expansion plans. While short-term headwinds persist in the California market, Glass House maintains its long-term bullish outlook. Its large cultivation assets provide a strong advantage. The company believes scale and quality will drive future margins. Therefore, investors continue to monitor Glass House as a top West Coast player.

[Read More]  These Cannabis Stocks Could Pay Off Big In The Future

Cresco Labs Inc. (CRLBF)

Cresco Labs is a multi-state cannabis operator based in Chicago, Illinois. The company is vertically integrated and offers products across nine key U.S. states. Its retail presence includes states like Florida, Illinois, Pennsylvania, and Massachusetts. Cresco Labs markets its dispensaries under the “Sunnyside” brand.

As of May 2025, Cresco operates 71 dispensaries across six states. Its stores are strategically located in both high-density urban centers and suburban areas. The company also owns several well-known consumer cannabis brands. These brands cater to a wide range of user preferences.

Cresco Labs has focused heavily on market depth rather than broad expansion. It prioritizes establishing strong brand loyalty in each region. This approach allows for efficient scaling and better customer service. The company’s mission is to normalize cannabis use through consistent and professional experiences. Cresco remains one of the largest cannabis companies by retail footprint in the U.S.

Latest Financials

Cresco Labs has delayed the release of its Q1 2025 earnings. However, previous performance trends provide some insight. In its last reported quarter, the company generated revenue of over $190 million, supported by strong retail performance in Florida and Illinois.

Gross profit margins hovered around 50 percent, consistent with prior quarters. The company previously reported a net loss, largely due to one-time restructuring costs. However, the adjusted EBITDA remained positive, showing that the business is generating operating cash flow.

Management has reaffirmed its commitment to reducing costs and improving margins. It is also working to optimize its supply chain. The delayed report is expected to include updates on the restructuring’s progress. Despite short-term challenges, Cresco remains financially stable. It continues to focus on market leadership in limited-license states.

U.S. Cannabis Stocks Catching Investor Attention This Week

In conclusion, the U.S. cannabis sector remains a dynamic and evolving space filled with both risk and opportunity. As legalization efforts continue across the country, investor interest in marijuana stocks is expected to grow. Companies like Planet 13, Glass House Brands, and Cresco Labs are positioning themselves for long-term success through strategic expansion and brand development. However, due to market volatility, it is essential to apply technical analysis and manage risk carefully.

Monitoring price action, volume, and key levels can help identify smarter entry points. Setting stop-losses and staying informed on regulatory changes will also support better decision-making. With proper research and a disciplined approach, investors can capitalize on momentum in this exciting sector. As always, focus on strong fundamentals, clear trends, and market-moving news to maximize cannabis-related opportunities. Now is the time to watch these top marijuana stocks as the U.S. industry moves toward broader acceptance.

The post Top Performing U.S. Marijuana Stocks to Watch in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to gain momentum in 2025. Experts estimate the market will surpass $45 billion this year. Many states are pushing new legislation to legalize adult-use cannabis. Recreational marijuana is now legal in almost half of the United States. This trend boosts investor confidence across the North American cannabis sector. Canadian companies with exposure to the U.S. market stand to benefit. Recent discussions at the federal level signal possible regulatory reform. These changes may include reclassifying cannabis to a lower risk category. If approved, this could open doors for wider medical research and commercial growth. Therefore, Canadian cannabis stocks are worth watching this week. They offer exposure to both Canadian and potential U.S. demand. Investors are watching for the next catalyst that could move these stocks sharply.

At the same time, it is critical to use technical analysis and proper risk management. Cannabis stocks can be highly volatile. Traders often look for breakout patterns and support zones on price charts. These patterns help identify high-probability entry points. Risk management involves setting stop-loss levels and avoiding oversized positions. It’s important to stay patient and avoid emotional trades. Because cannabis stocks react strongly to policy headlines, investors should track news closely. But no strategy is complete without discipline. Staying consistent with chart analysis and risk control helps limit damage from sudden reversals. As a result, combining market awareness with technical tools can lead to better decisions. This week, several Canadian stocks are forming key setups. Traders should stay focused and use risk control to capitalize on these potential moves.

[Read More] These 3 Marijuana Stocks Could Be The Winners You Need

Top Canadian Cannabis Stocks to Watch in May 2025

1. Tilray Brands Inc. (NASDAQ: TLRY)
2. Canopy Growth Corporation (NASDAQ: CGC)
3. Village Farms International Inc. (NASDAQ: VFF)

Tilray Brands Inc. (TLRY)

Tilray Brands Inc. is a Canadian-based cannabis company with global operations. It focuses on cannabis, wellness products, and beverages. In the U.S., Tilray has expanded its presence through partnerships and acquisitions in the craft beer and wellness industries. Though it does not directly operate cannabis dispensaries in the U.S., its brand awareness is growing. Its beverage brands are distributed in multiple states. Tilray’s strategy includes waiting for U.S. federal legalization before deeper cannabis integration. Meanwhile, the company maintains a strong distribution network across North America. It continues to be one of the most recognized names in the cannabis industry. Its diversification outside of cannabis helps reduce reliance on one sector. Therefore, Tilray remains a unique play among Canadian cannabis stocks. As legalization efforts expand, investors keep Tilray on their radar. Its U.S. strategy hinges on long-term positioning rather than short-term dispensary count.

Latest Financials

Tilray’s latest financial report showed steady revenue growth despite challenges. Revenue increased slightly year-over-year, driven by stronger cannabis sales and beverage distribution. However, net losses remained substantial due to impairments and restructuring charges. Gross margins improved thanks to operational efficiencies and product pricing strategies. The company also lowered debt through repayments, helping improve its overall balance sheet. Cash reserves stayed healthy, giving it flexibility in future expansion. Operating costs remained high, but management has taken steps to reduce them. Tilray adjusted its full-year revenue outlook to reflect current market trends. While the company is not yet profitable, it continues to focus on long-term sustainability. Investors are watching closely for further improvements in earnings and margins. Continued growth in its beverage segment adds diversity. The company’s U.S. exposure offers long-term upside once federal reform occurs. Risk remains, but Tilray’s brand power and footprint provide a foundation for future performance.

[Read More] The Best Marijuana To Make Potential Profits In 2025

Canopy Growth Corporation (CGC)

Canopy Growth Corporation is another leading cannabis company based in Canada. It operates internationally with strong medical and recreational cannabis divisions. Canopy does not own or operate U.S. dispensaries but has set up structures to enter once legal barriers fall. The company holds strategic stakes in several American cannabis firms, preparing for a post-legalization landscape. Canopy has built brand equity through innovative cannabis formats. These include dried flower, vapes, edibles, and medical-grade cannabis products. In Canada, Canopy remains a top-five cannabis supplier by market share. The company continues to focus on research and development to support product quality. Additionally, Canopy maintains a presence in medical cannabis markets across Europe and Australia. Though not directly present in U.S. retail, its groundwork may pay off. With U.S. legalization gaining momentum, Canopy could enter more aggressively. Its patient approach is designed to minimize legal risks while maximizing potential entry.

Latest Financials

Canopy’s recent financials reflect both progress and challenges. Revenue declined slightly but remained stable compared to peers. Sales growth in medical cannabis and international markets helped offset declines in other segments. The company saw increased sales from higher-margin products like vaporizers and medical offerings. However, Canopy continues to report operating losses as it invests in restructuring. The company narrowed its focus, divesting from underperforming businesses and assets. Cost-cutting measures began to show results through smaller quarterly losses. Cash reserves declined but remained adequate to support operations through 2025. The company also reduced its debt obligations through early repayments. While losses persist, the path toward leaner operations is becoming clearer. Gross margin improvements are encouraging signs of better efficiency. Analysts are cautiously optimistic, awaiting signs of revenue reacceleration. Canopy’s long-term plan depends heavily on U.S. legalization. Until then, the focus remains on global medical markets and streamlining operations.

[Read More] Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025

Village Farms International Inc. (VFF)

Village Farms International Inc. started as a greenhouse vegetable producer before pivoting to cannabis. The company now operates a large cannabis segment under the Pure Sunfarms brand. It is known for cost-efficient cultivation and a vertically integrated business model. Pure Sunfarms is one of Canada’s largest cannabis producers by volume. While Village Farms has no retail dispensaries in the U.S., it distributes CBD and hemp products across several states. Its U.S. exposure comes mainly through its Texas-based vegetable business and its hemp operations. The company has positioned itself to expand in the U.S. cannabis market once legalization advances. Meanwhile, its Canadian operations continue to grow steadily. Village Farms relies on its agricultural expertise to maintain low production costs. It also benefits from tight quality control since it handles cultivation, packaging, and distribution internally. This structure allows the company to adjust faster to changing market demands.

Latest Financials

Village Farms’ most recent earnings showed strength in its Canadian cannabis division. Revenue grew at a double-digit pace due to higher sales volume. However, operating expenses and inventory write-downs weighed on profitability. Gross margins remained competitive, thanks to low production costs. The company faced short-term headwinds but expects improvements in the second half of 2025. Village Farms extended its compliance period with the Nasdaq due to a low share price. Management expressed confidence in regaining compliance without a reverse split. The company also announced upcoming financial updates and strategic reviews. Its balance sheet remains stable, with moderate debt and consistent cash flow. Operating efficiency has improved year-over-year despite macroeconomic pressure. Village Farms’ long-term strategy includes expanding internationally and preparing for U.S. cannabis entry. The stock remains volatile, but value investors appreciate its low cost base. Its conservative capital management provides some downside protection for long-term holders.

Blooming Opportunities: Top Canadian Cannabis Investments This May

In May 2025, Tilray, Canopy Growth, and Village Farms represent three very different cannabis investment stories. Tilray offers diversification and brand recognition. Canopy Growth provides international exposure and regulatory preparedness. Village Farms brings cost leadership and operational focus. Each company faces headwinds, yet each is well-positioned to benefit from future industry growth. Investors should monitor key financial metrics and policy changes. Technical analysis and risk management remain crucial when trading cannabis stocks. As the U.S. edges closer to federal reform, Canadian players could gain significant ground.

The post High Potential: Canadian Cannabis Stocks Making Waves in May 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand, driven by rising demand and broader state-level legalization. By the end of 2025, analysts expect the market to exceed $45 billion in value. Currently, adult-use cannabis is legal in nearly half of the U.S. states. This trend fuels investor interest, especially in marijuana penny stocks. These low-priced equities offer high-risk, high-reward opportunities. Because of their affordability, they attract retail traders seeking large percentage gains. As legalization advances, more small-cap cannabis firms are positioned for explosive growth. Therefore, keeping these stocks on a weekly watchlist is a smart move for active traders.

However, it’s essential to apply disciplined strategies. Marijuana penny stocks are highly volatile and can change direction quickly. Technical analysis helps traders identify support and resistance levels. It also highlights potential breakout patterns and price reversals. Just as important, risk management protects capital. Traders should use stop-loss orders and avoid overexposure. With proper strategy and timing, these stocks can present compelling short-term opportunities.

Here are three top marijuana stocks to watch in May 2025: Planet 13 Holdings (PLNH), FLUENT Corp. (formerly Cansortium, CNTMF), and Ayr Wellness (AYRWF). Each company has a significant presence in the U.S. cannabis market and has shown notable developments in recent financials.

[Read More] The Best Marijuana To Make Potential Profits In 2025

Weekly Watchlist: Promising Marijuana Penny Stocks with Breakout Potential

1. Planet 13 Holdings (OTC: PLNH)
2. FLUENT Corp. (formerly Cansortium, OTC: CNTMF)
3. Ayr Wellness (OTC: AYRWF)

Planet 13 Holdings (PLNH)

Planet 13 Holdings is a vertically integrated cannabis company headquartered in Las Vegas, Nevada. It operates the world’s largest dispensary, located just off the Las Vegas Strip. In addition to its flagship location, Planet 13 has expanded its footprint across several states. As of April 2025, the company operates 37 dispensaries nationwide, including 33 in Florida. This expansion into Florida has been a significant growth driver for the company.

Latest Financials

In Q4 2024, Planet 13 reported revenue of $30.3 million, marking a 31.8% increase year-over-year. This growth was primarily driven by the company’s expansion in Florida. However, the company faced challenges with a net loss of $26.4 million, which included an $18.9 million non-cash impairment loss. The gross profit for the quarter was $13.1 million, representing a margin of 43.2%, down from 47.8% in the previous year. The decline in gross margin was attributed to industry-wide price compression and targeted discounting in Florida. Despite these challenges, Planet 13’s expansion strategy and strong presence in key markets position it as a notable player in the cannabis industry.

[Read More] Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025

FLUENT Corp. (formerly Cansortium, CNTMF)

FLUENT Corp., previously known as Cansortium Inc., is a multi-state cannabis operator based in Tampa, Florida. The company operates under the FLUENT brand and has a significant presence in Florida, Texas, Pennsylvania, and New York. As of early 2025, FLUENT has expanded its operations through the acquisition of RIV Capital, adding New York retail, wholesale, and cultivation operations to its portfolio. This strategic move has enhanced FLUENT’s footprint in the U.S. cannabis market.

Latest Financials

In 2024, FLUENT reported annual revenue of $103.6 million, reflecting a 6.4% year-over-year increase. The company’s Q4 2024 revenue was $24.9 million, a slight decrease compared to the previous year. Florida operations contributed significantly, with revenue at $20.3 million. Adjusted gross profit for the quarter was $10.0 million, representing 40.1% of revenue. Adjusted EBITDA stood at $3.0 million, driven by higher sales in Florida. FLUENT’s strategic acquisitions and consistent financial performance make it a noteworthy company in the cannabis sector.

[Read More] April 2025 Ancillary Cannabis Stock Watchlist: Three Companies Powering the Industry

Ayr Wellness (AYRWF)

Ayr Wellness is a vertically integrated, multi-state cannabis operator headquartered in Miami, Florida. The company operates over 90 licensed dispensaries across eight states, including Florida, Pennsylvania, and New Jersey. Ayr has been focusing on expanding its retail footprint and enhancing its product offerings to cater to a diverse customer base.

Latest Financials

For the full year 2024, Ayr Wellness reported generating $9.6 million in cash flow from operations. The company ended the year with a cash balance of $35.5 million, down from $50.6 million at the end of Q3 2024. In addition, Ayr secured $30 million in financing for a new Florida cultivation facility and successfully deferred $400 million in debt maturity to 2026. Despite revenue headwinds, Ayr’s strategic financial decisions and expansion efforts position it as a significant player in the cannabis industry.

Top Undervalued Cannabis Penny Stocks for Technical Traders

These companies—Planet 13 Holdings, FLUENT Corp., and Ayr Wellness—have demonstrated significant developments in their operations and financials, making them noteworthy stocks to watch in the cannabis sector for May 2025.

The post Best Cannabis Penny Stocks to Add to Your May 2025 Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues expanding rapidly, with projections suggesting it could reach $45 billion by 2025. More states are legalizing cannabis for medical and recreational use, boosting demand across the nation. Currently, 24 states allow adult-use cannabis, supporting thousands of dispensaries and grow operations. Additionally, the industry provides over 440,000 full-time jobs, strengthening its economic importance. Meanwhile, recent developments in federal policy signal possible changes ahead. Lawmakers are pushing for cannabis reform, and discussions around federal reclassification have gained momentum. As a result, investor interest is rising steadily, especially in real estate tied to cannabis operations. However, navigating this evolving market requires careful attention and research. Therefore, focusing on cannabis REITs with proven portfolios and strong tenants remains a smart strategy. In particular, companies that operate across multiple states offer added stability and diversification.

Given the industry’s volatility, investors must also use technical analysis when trading cannabis REITs. Watching price trends, volume shifts, and key support levels is crucial for success. Furthermore, setting clear risk management rules helps protect capital during uncertain periods. Stop losses, position sizing, and realistic targets should be part of every trade plan. This disciplined approach allows investors to handle price swings with more confidence. Meanwhile, staying updated on legalization headlines ensures you are not blindsided by regulatory news. Today’s top cannabis REITs combine steady financials with long-term growth potential. Innovative Industrial Properties, Chicago Atlantic Real Estate Finance, and NewLake Capital Partners all offer strong opportunities this week. Their diversified exposure to cultivation and retail properties gives them important advantages. As momentum builds across the cannabis sector, these REITs stand ready to capitalize on expanding demand.

Cannabis REIT Stocks Offering Strong Dividends and Growth Potential

As the cannabis industry expands, real estate investment trusts (REITs) are playing a growing role in its infrastructure. These specialized REITs lease properties to cannabis operators, providing vital capital and stability. In April 2025, three cannabis REITs are showing strong fundamentals and strategic growth. These include Innovative Industrial Properties (IIPR), Chicago Atlantic Real Estate Finance (REFI), and NewLake Capital Partners (NLCP). Each REIT operates differently, but all are positioned to benefit from the sector’s continued growth and regulatory momentum.

[Read More] These 3 Marijuana Stocks Could Be The Winners You Need

Top 3 Cannabis REITs to Watch in April 2025

1. Innovative Industrial Properties, Inc. (NYSE: IIPR)
2. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI)
3. NewLake Capital Partners, Inc. (OTC: NLCP)

Innovative Industrial Properties, Inc. (IIPR)

Innovative Industrial Properties is the most recognized name in cannabis real estate. The company owns and leases properties to licensed operators. IIPR’s focus is on cultivation and processing facilities across legalized U.S. states. As of April 2025, IIPR holds a portfolio of 109 properties in 19 states. The largest concentration of assets is in Pennsylvania, a key medical market. These properties are mission-critical for operators, making IIPR an essential player. The company signs long-term, triple-net leases, ensuring consistent rental income. Its tenants include several multistate operators with a national footprint. Because of this, IIPR has become a preferred landlord in the cannabis space. Its structure offers exposure to the industry with reduced operational risk. As legalization efforts expand, IIPR’s model becomes even more relevant.

Financially, IIPR remains strong. In the most recent full-year report, total revenue exceeded $300 million. Net income was solid, driven by stable lease payments and renewals. The company maintained a conservative debt profile, which supports long-term sustainability. Dividends have remained consistent and generous, rewarding shareholders. The payout ratio is healthy, which reflects disciplined cash flow management. IIPR’s quarterly dividend was recently increased, showing confidence in future earnings. Moreover, occupancy rates across its portfolio remain near 100%. Despite market fluctuations, IIPR continues to deliver strong financial performance. This combination of reliable income and exposure to a growing sector makes IIPR a compelling REIT to watch this month.

[Read More] April 2025 Ancillary Cannabis Stock Watchlist: Three Companies Powering the Industry

Chicago Atlantic Real Estate Finance, Inc. (REFI)

Chicago Atlantic Real Estate Finance is a commercial mortgage REIT serving the cannabis industry. The firm provides capital through senior secured loans. These loans support licensed cannabis companies seeking to expand or acquire real estate. REFI does not own dispensaries or grow operations itself. Instead, it earns income through interest payments on its loan portfolio. This makes REFI a financial backbone for cannabis expansion. Based in Chicago, the company focuses on underserved areas in need of funding. Its borrowers often include vertically integrated operators with limited access to traditional banking. Because cannabis remains federally illegal, REFI fills a critical financing gap. The company’s loan book is diversified across multiple states. It emphasizes risk control by targeting high-quality borrowers and conservative loan-to-value ratios. As a result, it has built a reputation for disciplined underwriting.

REFI’s financials continue to reflect strong execution. Total investment income has steadily increased year over year. Net interest income remains healthy, driven by rising yields and disciplined loan management. The company keeps operating costs low, which improves overall profitability. REFI also maintains minimal non-performing loans, showing effective risk oversight. In its latest quarter, REFI declared a steady cash dividend. The dividend yield remains attractive for income-focused investors. Earnings have comfortably covered the dividend, reinforcing the REIT’s financial strength. REFI’s performance is not reliant on real estate appreciation. Instead, it benefits from the demand for capital within the cannabis space. With its consistent returns and focused lending strategy, REFI is a strong REIT to watch. It offers exposure to cannabis growth without the operational volatility seen in other sectors.

[Read More] Top U.S. Pot Stocks for Growth in April 2025

NewLake Capital Partners, Inc. (NLCP)

NewLake Capital Partners is a cannabis-focused REIT that owns cultivation and retail properties. Headquartered in Connecticut, NLCP has a diverse property portfolio. As of April 2025, it owns 32 properties across 12 states. The company’s tenants are licensed operators in both medical and recreational markets. Pennsylvania is currently its most concentrated state. NLCP leases real estate to operators like Curaleaf, among others. These leases are long-term and often include built-in rent escalations. The properties include both dispensaries and grow facilities. This dual exposure gives NLCP a balanced revenue stream. The company uses sale-leaseback transactions to fund growth. This allows operators to raise capital while securing long-term space. NLCP’s strategy emphasizes tenant quality and conservative deal structures. The company’s flexible capital deployment supports continued expansion.

On the financial side, NLCP is showing steady growth. Revenue has increased year over year due to higher occupancy and added properties. Net income continues to rise, supported by disciplined spending and strong rental payments. The REIT has kept debt levels manageable, which protects against interest rate pressure. Dividend payouts remain consistent and competitive. In the latest quarter, NLCP distributed a regular dividend to shareholders. The payout has remained stable despite broader sector volatility. Its balance sheet remains healthy, with solid cash reserves and limited exposure to troubled tenants. NLCP is also evaluating new acquisition opportunities in emerging markets. As legalization trends advance, the company could benefit from new state entries. Overall, NLCP’s blend of operational focus and financial stability makes it a smart REIT to monitor this April.

Cannabis REITs With Strong Dividends and Promising Long-Term Growth

These three cannabis REITs each offer different ways to invest in the cannabis real estate market. IIPR focuses on property ownership and leasing to major operators. REFI offers financing through secured lending, avoiding real estate volatility. NLCP provides a hybrid model of retail and cultivation leasing with a stable tenant base. All three demonstrate strong financials and consistent dividend payouts. As the cannabis sector evolves, these REITs remain well-positioned. They balance growth with risk management, making them attractive for both conservative and growth-oriented investors. April 2025 could present new opportunities as more states expand cannabis programs. These REITs are ready to meet that demand.

The post Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis market continues to expand rapidly, with expected revenues reaching over $45 billion by 2025. This growth is fueled by rising consumer demand and ongoing state-level legalization. So far, 24 states and Washington, D.C. have legalized adult-use marijuana. Nearly 80% of Americans now live near a dispensary. Although federal reform has faced challenges, momentum continues to build. Most recently, a major legalization proposal in Florida failed to meet the required 60% threshold. However, efforts remain active across other key states. Many investors are now focused on the DEA’s expected rescheduling of cannabis. This move could reduce tax burdens and increase medical research. With this news circulating, top marijuana stocks are showing renewed volatility and opportunity this week.

With market sentiment shifting, traders must stay focused and disciplined. Technical analysis is critical when identifying price trends, breakouts, and support zones. In addition, traders should use stop-loss orders to protect against downside risk. Volatility remains high across cannabis names, so managing position size is essential. When evaluating marijuana stocks, it helps to track volume, recent news, and price structure. Watching how a stock reacts at key levels gives insight into trader sentiment. Moreover, staying updated on federal reform talks can provide early clues for breakout potential. While long-term growth is strong, short-term moves can be fast and unpredictable. By combining risk management with clear trade planning, investors can better capture gains while avoiding steep losses.

The Future of the Cannabis Industry

With legalization efforts gaining momentum, multi-state operators are positioned for significant growth. Among the top stocks to watch this month are Trulieve Cannabis Corp. (TCNNF), Curaleaf Holdings Inc. (CURLF), and Verano Holdings Corp. (VRNOF). These companies offer wide dispensary coverage, steady financials, and long-term potential. Additionally, investors should use technical analysis and solid risk management strategies when entering positions.

While recent pullbacks have created attractive entry points, traders must remain disciplined. Support and resistance levels should be closely monitored to identify key price action. By focusing on cannabis leaders with proven performance and strong cash flows, investors can position themselves ahead of possible policy shifts. Let’s take a closer look at three U.S. marijuana stocks to watch this April.

[Read More] 3 Marijuana Stocks To Buy Now And Sell When The Sectors Up

Top 3 U.S. Marijuana Stocks to Watch in April 2025

1. Trulieve Cannabis Corp. (OTC: TCNNF)
2. Curaleaf Holdings Inc. (OTC: CURLF)
3. Verano Holdings Corp. (OTC: VRNOF)

Trulieve Cannabis Corp. (TCNNF)

Trulieve Cannabis Corp. is a top multi-state operator based in Florida. It has built a dominant footprint across the Southeast. The company’s largest presence is in Florida, where it holds a leading market share. Trulieve also operates in states such as Pennsylvania, Arizona, and Ohio. As of early 2025, Trulieve manages 225 dispensaries across the U.S. The company continues to open new locations as adult-use markets expand. Trulieve recently launched adult-use operations in Ohio and expects more openings in 2025. Its strong retail network helps maintain its customer base and brand recognition. Trulieve’s commitment to growth keeps it ahead of smaller competitors. Its vertical integration strategy also allows for better control over quality and costs. This gives the company a competitive advantage in tight-margin markets. Overall, Trulieve remains a key player in U.S. cannabis retail and production.

Financial Performance

Trulieve reported revenue of $1.2 billion in 2024. This marked a 5% increase from the previous year. The company maintained a gross margin of 60%, signaling efficient cost management. Its adjusted EBITDA reached $420 million, or 35% of total revenue. This shows strong profitability despite pricing pressure across the industry. Trulieve also delivered $271 million in operating cash flow. Free cash flow came in at $150 million. These strong cash flows give the company financial flexibility. Trulieve continues to reduce debt while investing in growth. Capital discipline and cash generation are key strengths. The company is also exploring strategic acquisitions in emerging markets. These financial results show that Trulieve is well-positioned for future growth. Even with regulatory delays, the company’s fundamentals remain solid. Investors looking for strong cannabis stocks with profitability and scale should consider Trulieve this month.

[Read More] 2 Canadian Marijuana Stocks For Your Upcoming Watchlist

Curaleaf Holdings Inc. (CURLF)

Curaleaf Holdings Inc. is one of the largest cannabis companies in the U.S. The company is headquartered in Massachusetts and operates across 17 states. Its largest retail presence is in states like Florida, Arizona, and New Jersey. As of 2025, Curaleaf operates 151 dispensaries nationwide. It also owns 19 cultivation facilities, making it a fully integrated operator. Curaleaf focuses on high-growth, heavily populated markets. This gives it access to a wide customer base and strong brand exposure. The company continues to expand into new adult-use states. It is also positioning itself to benefit from possible federal reform. In 2024, Curaleaf strengthened its retail footprint and refined its product lines. It continues to launch new wellness and THC-infused products across the country. Overall, Curaleaf remains a market leader with national exposure and steady growth plans. It is one of the few cannabis companies with the scale to compete long-term.

Financial Performance

Curaleaf reported $1.34 billion in revenue for 2024. This made it one of the highest-grossing cannabis companies in the U.S. Its gross profit was $639 million, with a gross margin of 48%. Adjusted EBITDA came in at $75 million, with a 23% EBITDA margin. While the company posted a net loss of $71 million, it also reported an adjusted net income of $12 million. Curaleaf held $107 million in cash at year-end. This gives it the liquidity needed for continued expansion. The company remains focused on cost reduction and margin improvement. It has exited underperforming markets and is reallocating resources. Its financials show a commitment to streamlining operations and protecting shareholder value. Despite short-term losses, Curaleaf’s top-line growth and cash reserves support its long-term thesis. Investors should watch for margin expansion and operational updates in 2025.

[Read More] Marijuana Stocks in Focus: U.S. Companies Ready for a Breakout

Verano Holdings Corp. (VRNOF)

Verano Holdings Corp. is based in Illinois and is one of the fastest-growing multi-state cannabis operators. The company focuses on high-margin, high-growth adult-use and medical markets. Verano operates in 13 states, including Illinois, New Jersey, and Florida. Its largest presence is in Illinois, where it operates a strong retail and cultivation footprint. Verano has over 135 dispensaries and continues to grow through both organic expansion and acquisitions. In 2024, Verano opened several new stores and launched branded products across multiple markets. The company’s strategy emphasizes premium flower, edibles, and wellness-based cannabis. It also integrates technology into its retail experience to boost customer loyalty. With growing market share and product innovation, Verano is well-positioned for future industry consolidation. Investors are watching Verano’s ability to scale while maintaining product quality and brand value.

Financial Performance

Verano reported $879 million in revenue for 2024, which represented a 6% decline year-over-year. Despite the revenue dip, the company maintained strong gross margins of 51%. Verano’s adjusted EBITDA was $264 million, or 30% of total revenue. The company posted a net loss of $342 million, which included non-cash impairment charges. However, Verano generated $112 million in cash from operations. This allowed it to invest $99 million in capital expenditures. The company focused on infrastructure, cultivation upgrades, and store expansion. Verano’s strong EBITDA margins and positive cash flow remain key strengths. While net losses are a concern, they are mainly non-operational. Management is focused on improving cash efficiency and scaling its retail network. Verano remains an attractive pick for investors looking for a balance of growth and margin stability.

Best Marijuana Stocks for a Potential Upswing This Year

These three U.S. cannabis leaders—Trulieve, Curaleaf, and Verano—offer broad retail footprints, solid financials, and long-term potential. In a shifting regulatory environment, scale and efficiency are vital. Investors should continue to monitor these names for bullish technical setups and use proper risk management before entering trades.

The post Top U.S. Marijuana Stocks to Watch Now for a Potential Recovery appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The Canadian cannabis sector continues to evolve as companies expand operations and navigate industry challenges. Many Canadian cannabis producers are looking beyond their domestic market and establishing strong positions in the U.S. Despite federal restrictions. Some have developed partnerships, investments, or business strategies that position them well for eventual legalization.

This article highlights three leading Canadian cannabis stocks to watch in March. Aurora Cannabis Inc. (ACB), Village Farms International Inc. (VFF), and SNDL Inc. are key players in the sector. Each company has carved out its niche and demonstrated growth potential. Investors should consider recent financial results, expansion plans, and market positioning before making decisions.

[Read More] 3 Marijuana Stocks To Keep On Your Radar 2025

Top Canadian Cannabis Stocks for March 2025: Who’s Leading the Market?

1. Aurora Cannabis Inc. (NASDAQ: ACB)
2. Village Farms International Inc. (NASDAQ: VFF)
3. SNDL Inc. (NASDAQ: SNDL)

Aurora Cannabis Inc. (ACB)

Aurora Cannabis is a well-known Canadian cannabis producer with a focus on medical and recreational markets. The company has a global presence, supplying cannabis to more than 20 countries. Although its U.S. exposure is limited, Aurora has made strategic investments in the hemp-derived CBD market. The company operates multiple production facilities across Canada, ensuring large-scale supply capabilities. It does not currently own or operate dispensaries in the U.S., but it remains positioned for potential market expansion.

Aurora continues to focus on the medical cannabis industry, which provides steady revenue streams. It has also been expanding its premium cannabis offerings, targeting higher-margin products. The company’s research and development efforts aim to improve product quality and innovation. Aurora’s strong brand portfolio gives it a competitive edge in the Canadian market.

Financials

In its latest financial report, Aurora showed signs of stabilization. The company reported net revenue of C$63 million, reflecting steady medical cannabis sales. Gross margins improved due to cost-cutting initiatives and operational efficiencies. Aurora also reduced its debt significantly, strengthening its financial position. Despite challenges in the recreational market, its medical cannabis business remains a strong performer.

The company has been working on achieving profitability by controlling expenses. It continues to focus on reducing costs while increasing high-margin product offerings. Aurora’s long-term strategy includes potential U.S. market entry if federal legalization occurs. Investors should monitor its cash flow management and operational improvements.

[Read More] Marijuana Penny Stocks with Big Potential in March 2025

Village Farms International Inc. (VFF)

Village Farms International is a Canadian agricultural company that has successfully transitioned into the cannabis industry. Originally a greenhouse vegetable grower, it has leveraged its expertise in controlled-environment farming to cultivate cannabis. Through its wholly owned subsidiary, Pure Sunfarms, the company has become one of Canada’s leading cannabis producers.

While Village Farms primarily operates in Canada, it has expanded its footprint in the U.S. through its hemp and CBD business. The company has partnerships and supply agreements in various states. Although it does not own dispensaries, its cannabis products are widely distributed through licensed retailers. Pure Sunfarms’ strong brand presence has helped it capture a significant Canadian market share.

The company’s ability to produce cannabis at a low cost gives it a competitive advantage. Its large-scale greenhouses allow for efficient cultivation, resulting in higher margins. This efficiency has helped Village Farms maintain a strong financial position in the industry.

Financials

Village Farms reported a net revenue of C$74.6 million in its latest earnings release. The company’s cannabis segment contributed C$36.7 million, reflecting steady growth in market demand. Pure Sunfarms remained a top-selling brand in Canada, driving strong sales performance. The company also improved its gross margin to 34%, showcasing cost efficiencies.

One of the biggest highlights was its positive adjusted EBITDA, indicating profitability in a challenging market. Village Farms continues to focus on expanding its cannabis portfolio while maintaining its core agricultural operations. The company remains optimistic about its U.S. expansion strategy, particularly in the CBD and hemp space.

Village Farms’ financial health is a key strength. It has maintained strong cash reserves, allowing flexibility for future investments. The company is positioned well for long-term success by focusing on cost control and innovation. Investors should watch for updates on potential U.S. legalization developments.

[Read More] Investing in Cannabis: Best U.S. Marijuana Stocks to Track in March 2025

SNDL Inc.

SNDL is one of Canada’s most diversified cannabis companies. It operates in both the retail and cultivation sectors, making it a unique player in the market. The company owns over 200 dispensaries across Canada under brands like Spiritleaf and Value Buds. This substantial retail presence provides SNDL with direct consumer access, helping it capture market share.

In addition to retail operations, SNDL is a major cannabis producer with large-scale cultivation facilities. The company focuses on premium and value-priced cannabis products, catering to a broad consumer base. It has expanded its portfolio through strategic acquisitions, including liquor retail businesses. This diversification reduces reliance on cannabis sales alone.

Although its U.S. presence is currently limited, SNDL has made investments that could facilitate future entry into the American market. The company remains focused on expanding its market share and enhancing product offerings.

Financials

SNDL’s latest financial report showed revenue of C$230.5 million, reflecting strong retail sales growth. The company’s cannabis segment contributed C$66.2 million, driven by increased product demand. It also reported a significant improvement in gross margins, benefiting from operational efficiencies.

One of the key highlights was SNDL’s positive adjusted EBITDA, marking a shift towards profitability. The company has been aggressively reducing costs and streamlining operations. Its diversified business model provides stability in an otherwise volatile industry.

SNDL also strengthened its balance sheet, reducing debt and increasing cash reserves. This financial discipline gives it flexibility for future expansion. The company continues to focus on optimizing its retail operations and product offerings. Investors should monitor the company’s progress in scaling operations while maintaining profitability.

Canada’s Top Cannabis Stocks for March 2025 Strong Picks for Investors

The Canadian cannabis sector remains a dynamic and evolving industry. Companies like Aurora Cannabis, Village Farms International, and SNDL continue to adapt to market conditions and position themselves for future growth. Each company has its unique strengths, from Aurora’s global medical cannabis presence to Village Farms’ low-cost production model and SNDL’s extensive retail network.

Financial performance is improving, with cost-cutting measures and operational efficiencies playing key roles. Investors should monitor revenue trends, profitability metrics, and expansion strategies. With potential U.S. legalization on the horizon, these companies could benefit from broader market opportunities.

As the cannabis industry continues to develop, selecting the right stocks requires careful analysis. Investors should consider financial stability, market positioning, and long-term growth potential. Watching how these companies navigate challenges will be crucial in assessing their future success.

The post Investing in Cannabis: Best Canadian Stocks to Watch in March 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis real estate sector continues to grow as demand for property financing increases. Cannabis REITs provide capital for dispensaries and cultivation facilities, helping operators expand while securing long-term rental income. The U.S. cannabis market is projected to reach $71 billion by 2030, driven by new state legalizations and rising consumer demand. Recent news suggests that federal rescheduling of cannabis could move forward in 2024, potentially easing banking restrictions. This change would benefit cannabis REITs by improving tenant stability. Investors should focus on companies with strong balance sheets and reliable rental income to reduce risk.

Using technical analysis can help identify optimal entry points for cannabis REITs. Watching support and resistance levels, trading volume, and moving averages can improve decision-making. Proper risk management is essential, as stock prices can be volatile. Setting stop-loss levels and position sizing carefully can help protect capital. As legalization expands, REITs will play a key role in industry growth, making them attractive for long-term investors.

The cannabis real estate sector is critical to the industry’s growth. Real Estate Investment Trusts (REITs) provide capital for cannabis operators through property acquisitions and lease agreements. As the market expands, these REITs help companies scale operations while securing long-term rental income. With uncertain federal legalization, these REITs offer investors indirect exposure to the cannabis industry.

This month, three cannabis REITs stand out due to their performance and recent developments. Innovative Industrial Properties, Inc. (IIPR), NewLake Capital Partners, Inc. (NLCP), and Chicago Atlantic Real Estate Finance, Inc. (REFI) are among the top REITs to watch. They own and manage properties leased to leading cannabis operators in the U.S. Their financials, dividends, and acquisitions make them attractive investment options. Below is a closer look at these companies.

[Read More] 3 Important Marijuana Stocks Giving Investors Hope

Best Cannabis REITs to Buy Now for Stability and Passive Income

1. Innovative Industrial Properties, Inc. (NYSE: IIPR)
2. NewLake Capital Partners, Inc. (OTC: NLCP)
3. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI)

Innovative Industrial Properties, Inc. (IIPR)

Innovative Industrial Properties (IIPR) is one of the largest cannabis-focused REITs in the U.S. The company specializes in acquiring and leasing industrial properties to state-licensed cannabis operators. It has a diverse portfolio covering multiple states, including California, Florida, and Pennsylvania. These regions have some of the most established cannabis markets.

As of early 2024, IIPR owns over 100 properties across 19 states. Its tenants include major multi-state operators (MSOs) such as Curaleaf, Trulieve, and Green Thumb Industries. The company follows a sale-leaseback model, allowing cannabis businesses to free up capital while securing long-term leases. This strategy has positioned IIPR as a key player in the sector.

In its latest earnings report, IIPR showed strong revenue growth. For the third quarter of 2023, revenue reached $79.9 million, reflecting a 12% increase year-over-year. The company also reported a net income of $40.8 million, maintaining profitability despite market challenges.

One of IIPR’s main attractions is its dividend payments. The company offers a high-yield dividend, making it appealing to income-focused investors. However, concerns about tenant defaults have impacted its stock price. Some cannabis operators have struggled with cash flow, affecting lease payments.

Despite these challenges, IIPR continues to expand its portfolio. The company remains a leader in cannabis real estate, with solid financials and a growing market presence. Investors watching this stock should consider its stability, dividend returns, and the evolving regulatory landscape.

[Read More] Here Are 2 Top Marijuana Stocks To Know About

NewLake Capital Partners, Inc. (NLCP)

NewLake Capital Partners (NLCP) is a smaller but growing cannabis REIT. It focuses on acquiring retail and industrial properties leased to state-licensed cannabis operators. The company has built a strong presence in Illinois, Massachusetts, and Pennsylvania, which are key cannabis markets in the U.S.

NLCP owns 32 properties across 12 states, supporting both medical and recreational cannabis businesses. Its tenants include top cannabis operators like Cresco Labs, Columbia Care, and Trulieve. The company follows a triple-net lease model, meaning tenants cover property expenses, reducing NLCP’s operational risks. This structure ensures steady rental income and long-term growth potential.

Although smaller than IIPR, NLCP has positioned itself as a reliable REIT with consistent revenue growth. Its strategic property acquisitions and long-term leases offer stability in the cannabis real estate market. As legalization expands, the demand for quality real estate will likely drive NLCP’s growth.

In its most recent financial report, NLCP generated $13.4 million in revenue, marking a 9% year-over-year increase. Net income reached $6.2 million, reflecting solid profitability. The company’s funds from operations (FFO), a key REIT performance metric, also showed improvement.

NLCP pays a quarterly dividend, offering investors consistent returns. Its last report declared a dividend of $0.39 per share, making it an attractive option for income investors. The company maintains a strong balance sheet with low debt, giving it flexibility for future acquisitions.

Looking ahead, NLCP is expected to expand its property portfolio as more states legalize cannabis. The company’s growth strategy and focus on high-quality tenants position it well for long-term success. Investors interested in cannabis real estate should watch NLCP’s developments.

[Read More] Top U.S. Marijuana Penny Stocks to Watch in Q1 2025 for High-Growth Potential

Chicago Atlantic Real Estate Finance, Inc. (REFI)

Chicago Atlantic Real Estate Finance (REFI) is a unique player in the cannabis REIT sector. Unlike traditional REITs, REFI focuses on providing loans and credit facilities to cannabis operators. It helps businesses secure financing for expansion, property acquisitions, and operational needs.

REFI operates in some of the fastest-growing cannabis markets, including Michigan, Florida, and New Jersey. The company’s lending strategy allows it to work with both multi-state operators and independent cannabis businesses. By focusing on debt financing, REFI reduces exposure to property management risks while generating interest income.

The company has structured its investments to minimize default risks. Most of its loans are collateral-backed, ensuring that it can recover assets if borrowers face financial trouble. This approach has helped REFI maintain steady earnings while supporting cannabis industry growth.

In its latest earnings report, REFI posted $14.1 million in revenue, marking a 10% increase year-over-year. Net income came in at $7.2 million, reflecting strong profitability. The company’s loan portfolio continues to grow, with an emphasis on high-credit-quality borrowers.

REFI also offers a strong dividend yield, attracting income-focused investors. The company recently declared a dividend of $0.47 per share, reflecting its commitment to shareholder returns. As demand for cannabis financing increases, REFI is well-positioned to expand its lending activities.

Looking ahead, REFI plans to grow its loan portfolio and expand into new legal cannabis markets. The company’s focus on debt financing gives it a unique advantage in the sector. Investors seeking exposure to cannabis real estate with lower property management risks should consider REFI.

[Read More] 3 Marijuana Stocks That Could Soon Make Investors Big Profits

High-Yield Cannabis REITs to Watch in a Growing Market

The cannabis REIT sector remains a strong investment option despite market volatility. IIPR, NLCP, and REFI each offer unique opportunities for investors. IIPR stands out for its large portfolio and high dividend yield. NLCP is a smaller but growing REIT with a stable rental income. REFI provides financing solutions, reducing traditional REIT risks while maintaining strong earnings.

As cannabis legalization progresses, demand for real estate and financing will continue to grow. These REITs are critical in supporting cannabis businesses while offering investors potential long-term returns. Investors should monitor their financial performance and regulatory developments before making investment decisions.

The post 3 Must-Watch Cannabis REITs for Real Estate Investment in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stocks are in the same spot where the market is going to have issues with volatility. Due to the political landscape of passing federal reform or any cannabis laws, the next 4 years will be interesting. At this time most people inside Donald Trump’s cabinet are not in favor of legal cannabis.

Some of them are even working to reverse laws and make even more trouble for the legal market and its operators. Investor confidence in finding marijuana stocks to buy can be influenced by political circumstances. If investors perceive a hostile federal environment, they may be hesitant to invest, reducing capital flow into the sector.

Under the Trump administration, there is a lack of support for marijuana legalization at the federal level. This has led to uncertainty and has challenged the growth potential of cannabis companies. If similar sentiments continue in future administrations, it could hinder progress in federal reforms that would benefit the industry.

Still, there is much optimism as the demand and money being made from legal cannabis increases. Many companies are shown to be profitable as a business yet this success has not shown as much in the public sector. Still with hopes high for the future some marijuana stocks to watch could soon see moments of strong trading throughout 2025.

Top Marijuana Stocks For 2025

1. Jushi Holdings Inc. (OTC:JUSH)
2. SNDL Inc. (NASDAQ:SNDL)

Jushi Holdings Inc.

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. In recent news, the company announced its support for the of Adult Use cannabis in Pennsylvania.

Words From The Company

“Jushi and its subsidiaries’ hundreds of employees here in the Commonwealth of Pennsylvania are pleased that the legalization of cannabis is once again a priority for the legislative session. And while we agree that there are important budget implications to this policy, it is also critically important to extend public protections of the regulated medical market we’ve created to the adult use marketplace.”

[Read More] Mid-February Watchlist: Leading Cannabis REITs for Real Estate Growth

SNDL Inc.

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. Back in mid-January 2025 the company announced a partnership with HYTN Innovations Inc.

Under the agreement which was signed January 17, 2025, neither HYTN nor SNDL are obligated to exclusivity. While key milestones include the processing of three (3) commercial batches, there is no obligation regarding sales volume or pricing terms.

[Read More] Here Is How Marijuana Stocks Are Impact By The Cannabis Industry

Upon completion of the development phase, both parties may explore a commercial manufacturing agreement for vape cartridges.

The post These Marijuana Stocks Could Make The Difference In Your Portfolio appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The patience of some marijuana stock investors is still being tested. The public sector for cannabis is a victim of uncertainty and fear in more grey areas. What this means is in the USA there is no federal reform that protects legal operators in any way. Yet states have independently voted to legalize cannabis. From this legal markets are created and legal companies can now produce a federally illegal product.

This is where the grey area of legal cannabis thrives. However, this has also added unwanted levels of downward trading levels for the public side of the industry. The amount of progress and money being made since 2020 has left many people stunned. With all this success and through the ups and downs cannabis is now becoming more accepted as a social norm. This is part of the bigger picture for marijuana as hopes are high for the future of the industry at large.

As the public still shows heavy drops in trading this could be your window to find top marijuana stocks to buy at low share prices. You always want to buy low and sell high and create a game plan that works with your style of investing and trading. Always do your research and be as patient as things can change without warning. Below are several marijuana stocks to watch that could soon see a bounce in trading.

Marijuana Stocks To Watch 2025

1. Aurora Cannabis Inc (NASDAQ:ACB)
2. Tilray Brands, Inc. (NASDAQ:TLRY)
3. Cronos Group Inc.(NASDAQ:CRON)

Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis derivative products in Canada and internationally. In recent news, the company announced a supply agreement with SNDL.

Under this Agreement, SNDL is expected to supply Aurora with premium cannabis flower products grown at SNDL’s indoor facility. The term of the agreement is for three years with an option to extend and an estimated value of $27 million. Aurora and SNDL have an existing and successful supply relationship for the manufacturing of various cannabis products and input materials.

[Read More] Canadian Cannabis Market Update: Best Stocks to Track in February 2025

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

On February 5th the company announced it has partnered with Jet Blue. With this partnership, Jet Blue will serve The Surf Beer Golden Ale on its air crafts which is a product of Tilray.

Words From The Company

Vaughan Cutillo, Co-founder of Montauk Brewing, says, “We are proud and excited that JetBlue selected our Montauk Surf Beer Golden Ale to offer to travelers worldwide.”

[Read More] Ancillary Cannabis Stocks to Watch in February: Strong Picks for 2025

Cronos Group Inc.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany. Back in November 2024, the company reported its Q3 2024 earnings.

Third Quarter 2024

• Net revenue of $34.3 million in Q3 2024 increased by $9.5 million from Q3 2023.
• Gross profit of $3.6 million in Q3 2024 decreased by $0.4 million from Q3 2023.
• Adjusted Gross Profit of $10.7 million in Q3 2024 increased by $6.8 million from Q3 2023.
• Adjusted EBITDA of $(6.0) million in Q3 2024 improved by $9.2 million from Q3 2023. a

The post 3 Marijuana Stocks To Watch As Trading Momentum May Soon Rise appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to grow, offering significant opportunities for investors. In 2024, the legal cannabis market reached $34 billion in sales. Analysts expect it to surpass $50 billion by 2030 as more states legalize marijuana. Currently, 38 states allow medical cannabis, while 24 states permit recreational use. Recently, lawmakers introduced new federal legalization bills, sparking investor interest. However, marijuana stocks remain volatile, making penny stocks an attractive but risky option. These low-priced stocks can deliver high gains but require careful research. Traders should watch market trends, company fundamentals, and legalization updates.

Using technical analysis can help identify strong entry and exit points. Key indicators like moving averages, RSI, and volume trends provide insights into price movements. Risk management is essential, as penny stocks can be highly speculative. Setting stop-loss orders and position limits can help reduce potential losses. Investors should stay updated on industry news and regulatory changes for better decision-making.

The cannabis industry remains a volatile yet promising sector for investors. As federal legalization discussions continue, penny stocks present high-risk, high-reward opportunities. Many marijuana stocks trade at low prices due to market uncertainty. However, these companies continue expanding operations and generating revenue growth.

For February 2025, three marijuana penny stocks stand out: Cannabis Bioscience International Holdings, Inc. (CBSTF), Cansortium Inc. (CNTMF), and Cresco Labs Inc. (CRLBF). These companies operate in key U.S. markets and could benefit from potential policy shifts. Investors should closely monitor their financial performance, expansion strategies, and stock movements. Using technical analysis and proper risk management is crucial when trading penny stocks.

[Read More] Top Canadian Cannabis Stocks in 2025: What to Watch in January

Marijuana Penny Stocks to Watch in February 2025 as Industry Demand Grows

1. Cannabis Bioscience International Holdings, Inc. (OTC: CBSTF)
2. Cansortium Inc. (OTC: CNTMF)
3. Cresco Labs Inc. (OTC: CRLBF)

Cannabis Bioscience International Holdings, Inc.

Cannabis Bioscience International Holdings, Inc. (CBSTF) is a biotechnology-driven cannabis company. It focuses on research, product development, and medical cannabis applications. The company has a strong presence in California and Florida, where demand for cannabis-based treatments is high. CBSTF works closely with dispensaries, research institutions, and healthcare providers.

While it does not directly own dispensaries, it partners with several licensed operators. These partnerships help distribute its medical cannabis products across multiple states. The company specializes in cannabinoid-based formulations targeting pain management and neurological disorders. Its innovative approach to medical cannabis makes it a unique player in the industry. Investors should watch how CBSTF navigates regulatory challenges and expands its market reach.

CBSTF recently reported steady revenue growth, driven by increased demand for medical cannabis solutions. The company’s latest earnings showed a 10% rise in quarterly revenue compared to the previous year. This growth is largely due to expanded partnerships and new product launches.

Operating expenses remain a concern, as research and development costs are high. However, the company continues to secure funding through strategic partnerships and private investments. Its latest financial report also highlighted improved gross margins, which could support long-term sustainability.

If CBSTF maintains its growth trajectory, it could attract institutional investors. Regulatory changes favoring medical cannabis could further enhance its market position. Investors should keep an eye on profitability trends, licensing agreements, and new clinical trials.

[Read More] This Is What Could Happen To Marijuana Stocks In 2025

Cansortium Inc.

Cansortium Inc. (CNTMF) is a vertically integrated cannabis company based in Florida. It operates under the “Fluent” brand, serving medical cannabis patients across multiple states. The company has a strong presence in Florida, Texas, Pennsylvania, and Michigan. Florida remains its largest market, with over 30 dispensaries statewide.

Cansortium focuses on high-quality medical cannabis products, including flower, edibles, and vape cartridges. It continues expanding its footprint, particularly in Florida, where medical cannabis demand is growing. The company aims to capitalize on Florida’s potential shift toward recreational legalization. If legislation changes, CNTMF could see significant revenue growth.

CNTMF’s most recent earnings report showed solid revenue performance, with quarterly sales surpassing $20 million. Florida operations contributed the largest share, with same-store sales increasing. The company also reported an improvement in gross profit margins, reflecting better operational efficiency.

Despite revenue growth, CNTMF faces financial challenges. Debt remains a key issue, and management is actively working on restructuring strategies. The company is focusing on cost-cutting measures and optimizing supply chain operations. These efforts aim to improve long-term profitability and financial stability.

Investors should monitor debt-reduction plans, expansion efforts, and potential M&A activity. If Florida legalizes adult-use cannabis, CNTMF could experience a significant upside. However, cautious risk management is essential, given the stock’s volatility.

[Read More] 3 Marijuana Stocks And How The Sector Could Perform In 2025

Cresco Labs Inc.

Cresco Labs Inc. (CRLBF) is one of the largest multi-state cannabis operators in the U.S. The company has a strong retail and wholesale presence, making it a key industry player. Its largest markets include Illinois, Pennsylvania, and Ohio. Currently, Cresco operates over 60 dispensaries nationwide, with a focus on highly populated regions.

The company owns and operates the Sunnyside dispensary brand, which has gained consumer recognition. Cresco’s product portfolio includes flower, vapes, edibles, and concentrates, distributed across various retail locations. Its wholesale division supplies cannabis to over 1,000 dispensaries across multiple states.

CRLBF’s latest financials show strong revenue growth, exceeding $200 million in quarterly sales. However, profitability remains a challenge due to high tax burdens and operational costs. The company continues to focus on cost efficiency, aiming to improve EBITDA margins.

Recent financial reports indicate increased gross margins, driven by improved supply chain management. However, net losses persist due to high regulatory compliance costs. Cresco’s expansion into new adult-use markets, including Ohio and Pennsylvania, could drive future revenue growth.

Investors should track cash flow trends, cost-cutting initiatives, and state-level legalization efforts. If Cresco maintains strong revenue momentum, it could be a leading player in the evolving cannabis market. However, market volatility and federal policy changes remain key risks.

[Read More] 2 Top Tier Cannabis Stocks For Better Investing 2025

Undervalued Cannabis Penny Stocks to Watch in February for Potential Upside

Marijuana penny stocks present exciting opportunities, but they come with significant risks. CBSTF, CNTMF, and CRLBF each offer unique strengths and potential for growth. Cannabis Bioscience (CBSTF) specializes in biotech-driven cannabis solutions, while Cansortium (CNTMF) dominates the Florida medical market. Cresco Labs (CRLBF) remains a major multi-state operator with strong wholesale revenue.

Investors should conduct thorough research before investing in cannabis stocks. Monitoring financial performance, expansion plans, and industry trends is essential. As federal legalization discussions continue, these stocks could see increased investor interest. However, proper risk management is necessary due to industry volatility.

By staying informed and using technical analysis, investors can navigate the cannabis penny stock sector more effectively. Keep an eye on these companies as they position themselves for potential future growth.

The post February’s Top Marijuana Penny Stocks: High-Growth Potential in a Volatile Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..